Targin for Non-cancer Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

September 1, 2013

Primary Completion Date

March 30, 2017

Study Completion Date

March 30, 2017

Conditions
Non Cancer Pain
Interventions
DRUG

Oxycodone/naloxone prolonged release tablets

Trial Locations (31)

Unknown

Guangzhou First People's Hospital, Guangzhou

Second Affiliated Hospital of Shan Tou University Medical College, Shantou

Hebei General Hospital, Shijiazhuang

Beijing friendship hospital, Beijing

Beijing Tiantan Hospital, Beijing

Beijing Union hospital, Beijing

Peking Union Medical College Hospital, Beijing

Peking University Third Hospital, Beijing

The first affiliated hospital of Bengbu medical collage, Bengbu

The third Xiangya hospital of central south university, Changsha

The thrid Xiangya Hospital of central south university, Changsha

Xiangya hospital central south university, Changsha

West China Hospital, Chengdu

Daping Hospital, Chongqing

South West hospital, Chongqing

Fuzhou general hospital, Fuzhou

The third affiliated hospital Sun yat-sen university, Guangzhou

Guizhou Provincial People's Hospital, Guizhou

The second affiliated hospital of Harbin medical university, Harbin

Shandong Provincial Hospital, Jinan

Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai

Shanghai Changhai Hospital, Shanghai

Shanghai Sixth People's Hospital, Shanghai

Zhongshan Hospital Fudan University, Shanghai

The first affiliated hospital of Shantou university medical college, Shantou

The general hospital of Shenyang military, Shenyang

The central hospital of Wuhan, Wuhan

Tongji Hospital, Wuhan

Union Hospital Tongji medical college, Wuhan

The affiliated hospital of Xuzhou medical university, Xuzhou

Second affiliated hospital of Zhejiang university, Zhejiang

All Listed Sponsors
lead

Mundipharma (China) Pharmaceutical Co. Ltd

INDUSTRY

NCT01918098 - Targin for Non-cancer Pain | Biotech Hunter | Biotech Hunter